MediSure Canada to provide testing supplies to federally incarcerated diabetic population
VANCOUVER, BC / ACCESSWIRE / November 9, 2022 / EMPOWER CLINICS INC (CSE:EPW)(OTCQB:EPWCF) (“Empower Clinics” or the “Company”), an integrated healthcare company – serving patients through medical centers, telemedicine platforms, a medical device company, and a high complexity medical diagnostics laboratory – announced today that Correctional Service of Canada (CSC) has awarded a three year contract to MediSure Canada to provide diabetes testing solutions to inmates in federal prisons.
The Correctional Service of Canada (CSC) is the federal government agency responsible for administering sentences of a term of two years or more, as imposed by the courts. CSC is responsible for managing institutions of various security levels and supervising offenders under conditional release in the community.
The multi-year contract is worth an approximate total of $1.5MM CAD. This is the third time that MediSure Canada has won the CSC contract as part of a public Request for Proposal (RFP) tendering process.
“MediSure Canada continues to perform, delivering results in both sales and launching innovative products”, said Steven McAuley, Chairman and CEO of Empower Clinics. “It’s an impressive feat when a client as prominent as the Government of Canada is a happy repeat customer of our diabetes testing solutions. This sales endorsement bodes well for our revenue generation efforts into other federal or provincial government agencies in Canada. Governments know that diabetes is one of the most common chronic diseases affecting people living in Canada”.
“I am proud of the team at MediSure for their hard work to win this contract with an agency of Government of Canada, especially given that it is our third consecutive win with this same client,” stated Mario Cortis, President of MediSure Canada Inc. “Building a government customer base with trust and loyalty towards the MediSure brand is a top priority. We know repeat customers tend to spend more, are more likely to try our new products, refer new government clients and overall help to improve our profitability over time.”
MediSure Canada is a wholly owned subsidiary of Empower Clinics. It is a Canadian medical device company dedicated to bringing value to the high cost of diabetes, both to patients and insurers. Medisure also has developed and launched new Health Canada approved at-home testing products sold and distributed online and through its network of pharmacies. MediSure’s products are designed and manufactured with safety and durability in mind, meeting all ISO standards with world-class quality controls. Equipped with features that lead the industry in technology, MediSure’s products are designed to offer a user-friendly experience and an overall improved approach to diabetes management.